(Q43749603)

English

Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant

scientific article published on 30 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Ajay K Israni

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Jon J Snyder

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Melissa A Skeans

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bertram L Kasiske

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PORT Investigators

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

30 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

748-757

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Prevalence of the metabolic syndrome in kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome and coronary artery calcification in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

One-year post-transplant weight gain is a risk factor for graft loss

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic cardiovascular syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Strategies to reduce toxicities and improve outcomes in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome is related to long-term graft function in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Cardiovascular complications after renal transplantation and their prevention.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Management of cardiovascular disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Low levels of high-density lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Association of metabolic syndrome with development of new-onset diabetes after transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Metabolic syndrome after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01488.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2012.01488.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43749603&oldid=2103021735"